期刊文献+

单纯超声引导下经皮二尖瓣球囊扩张术治疗妊娠期中重度二尖瓣狭窄的临床疗效

Clinical efficacy of percutaneous balloon mitral valvuloplasty under echocardiographic guidance for moderate to severe mitral stenosis during pregnancy
原文传递
导出
摘要 目的探讨单纯超声引导下经皮二尖瓣球囊扩张术治疗妊娠期中重度二尖瓣狭窄患者的效果。方法纳入2018年8月—2022年6月于阜外医院明确诊断为中重度二尖瓣狭窄并接受单纯超声引导下经皮二尖瓣球囊扩张术治疗的妊娠期患者,对其基线资料、手术情况、超声心动图结果和随访结果进行回顾性分析。结果共纳入3例妊娠期患者,年龄30~35岁,孕周19~26周,纽约心脏协会(NYHA)心功能分级均为Ⅲ级。3例患者均成功完成手术,平均二尖瓣瓣口面积由术前0.9 cm^(2)增加至术后2.1 cm^(2),平均跨瓣压差由术前15.0 mm Hg降至术后6.7 mm Hg,无围术期不良事件。术后随访3~48个月,3例患者均顺利完成分娩并恢复正常生活,母胎安全。结论单纯超声引导下经皮二尖瓣球囊扩张术治疗妊娠期中重度二尖瓣狭窄患者安全有效,母胎结局满意。 Objective To investigate the effect of percutaneous balloon mitral valvuloplasty under echocardiographic guidance for patients with moderate to severe mitral stenosis during pregnancy.Methods A retrospective observational study was conducted to include pregnant women who were diagnosed with moderate to severe mitral stenosis and underwent percutaneous balloon mitral valvuloplasty under echocardiographic guidance in Fuwai Hospital from August 2018 to June 2022,and their baseline characteristics,surgical outcomes,echocardiographic results,and follow-up results were analyzed.Results A total of 3 pregnant women aged 30-35 years,with gestational age of 19-26 weeks,and New York Heart Association(NYHA)function classⅢwere included.All the procedures were successfully performed.The mitral valve orifice area increased from 0.9 cm^(2)preoperatively to 2.1 cm^(2)postoperatively.The mean transvalvular pressure gradient decreased from 15.0 mm Hg preoperatively to 6.7 mm Hg postoperatively.No perioperative adverse events occurred.The follow-up time ranged from 3 to 48 months.All patients delivered uneventfully and returned to normal life,with maternal-fetal safety.Conclusion Percutaneous balloon mitral valvuloplasty under echocardiographic guidance is a feasible and effective procedure for the treatment of patients with moderate to severe mitral stenosis in pregnancy,with satisfactory maternal-fetal outcomes.
作者 魏培坚 李文超 李航 房芳 张凤文 欧阳文斌 李世国 张德元 林逸贤 潘湘斌 WEI Peijian;LI Wenchao;LI Hang;FANG Fang;ZHANG Fengwen;OUYANG Wenbin;LI Shiguo;ZHANG Deyuan;LIN Yixian;PAN Xiangbin(Department of Structural Heart Disease,National Center for Cardiovascular Disease,Fuwai Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,100037,P.R.China;National Health Commission Key Laboratory of Cardiovascular Regeneration Medicine,Key Laboratory of Innovative Cardiovascular Devices,Chinese Academy of Medical Sciences,National Clinical Research Center for Cardiovascular Diseases,Beijing,100037,P.R.China;Life Tech Scientific Company,Shenzhen,518057,Guangdong,P.R.China;Hong Kong Canossa Hospital,Asia Heart Center,Hongkong,999077,P.R.China)
出处 《中国胸心血管外科临床杂志》 CSCD 北大核心 2024年第9期1333-1337,共5页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 中国医学科学院医学与健康科技创新工程(2021-I2M-1-065) 国家重点研发计划(2022YFC2503400) 中央高水平医院临床科研业务费专项(2022-GSP-GG-18,2023-GSP-RC-04) 国家重大科研仪器研制项目(82327801)。
关键词 妊娠 二尖瓣狭窄 经皮二尖瓣球囊扩张术 超声引导介入手术 Pregnancy mitral stenosis percutaneous balloon mitral valvuloplasty echocardiography-guided intervention
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部